MGLCX
Price
$15.65
Change
+$0.03 (+0.19%)
Updated
Apr 23 closing price
Net Assets
2.19B
MGLMX
Price
$15.66
Change
+$0.03 (+0.19%)
Updated
Apr 23 closing price
Net Assets
2.19B
Ad is loading...

MGLCX vs MGLMX

Header iconMGLCX vs MGLMX Comparison
Open Charts MGLCX vs MGLMXBanner chart's image
MFS Global Real Estate C
Price$15.65
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets2.19B
MFS Global Real Estate R4
Price$15.66
Change+$0.03 (+0.19%)
VolumeN/A
Net Assets2.19B
MGLCX vs MGLMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLCX vs. MGLMX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLCX is a Buy and MGLMX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLCX (2.19B) and MGLMX (2.19B) have equal amount of cash in the bank . MGLMX pays higher dividends than MGLCX: MGLMX (2.61) vs MGLCX (1.34). MGLCX was incepted earlier than MGLMX: MGLCX (10 years) vs MGLMX (10 years). MGLCX (1.95) is less costly to investors than MGLMX (0.95). MGLCX (48.00) and MGLMX (48.00) have comparable annual turnover. MGLMX has a lower initial minimum investment than MGLCX: MGLMX (0) vs MGLCX (1000). MGLMX annual gain was more profitable for investors over the last year : 1.50 vs. MGLCX (0.50). MGLMX return over 5 years is better than : 21.39 vs. MGLCX (15.33).
MGLCXMGLMXMGLCX / MGLMX
Total Expense Ratio1.940.94206%
Annual Report Gross Expense Ratio1.950.95205%
Fund Existence10 years10 years-
Gain YTD-2.981-2.677111%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B2.19B100%
Annual Yield % from dividends1.342.6151%
Returns for 1 year0.501.5033%
Returns for 3 years-23.88-21.54111%
Returns for 5 years15.3321.3972%
Returns for 10 years-1.5011.24-13%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGLX64.42N/A
N/A
Janus Henderson Global Life Sciences T
IVITX20.33N/A
N/A
VY® Invesco Growth and Income S2
RGGCX21.45N/A
N/A
Victory RS Global C
RALIX10.34N/A
N/A
Lazard Real Assets Instl
BUIBX19.84N/A
N/A
Buffalo Flexible Allocation Inst